[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100370529":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":24,"centralContacts":29,"locations":36,"responsibleParty":96,"collaborators":19,"id":98,"slug":19,"hasResults":99,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":103,"eligibilityCriteria":104,"healthyVolunteers":99,"sex":105,"minAge":106,"maxAge":19,"enrollmentInfo":107,"targetDuration":19,"studyType":110,"phases":111,"briefSummary":113,"conditions":114,"keywords":118,"overallStatus":39,"whyStopped":19,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":132},{"fullName":5,"class":6},"Institut du Cancer de Montpellier - Val d'Aurelle","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Biological collection","EXPERIMENTAL","Biological collection\n\nFor all the patients include in the study :\n\nsamples of blood samples collected before and during treatment. In parallel to this biological collection, standardized clinical data will be entered into a database\n\nAncillary study :\n\nFor metastatic thyroïd cancer and neuroendocrine tumor : anapath blocks of the initial diagnosis will be archived and dosimetric data will be collected for the cycle 1 For neuroendocrine tumor : blood sample additionnal will be realized at the cycle 1 (pre and post treatment)",[13,14],"Other: Biological collection","Other: tumor collection",[16,20],{"type":6,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"The biological collection will also include samples of blood samples collected before and during treatment.",[9],null,{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":19},"tumor collection","Tumor collection (diagnosis) will be done for thyroid cancer and neuroencrine",[9],[25],{"name":26,"affiliation":27,"role":28},"Emmanuel DESHAYES, MD","Institut régional du Cancer Montpellier","STUDY_CHAIR",[30],{"name":31,"role":32,"phone":33,"phoneExt":34,"email":35},"Aurore MOUSSION","CONTACT","0467613102","+33","DRCI-icm105@icm.unicancer.fr",[37,53,67,83],{"facility":38,"status":39,"city":40,"state":41,"zip":19,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Hopital Haut Lévêque","RECRUITING","Bordeaux","Aquitaine","France",{"type":44,"coordinates":45},"Point",[46,47],-0.58046,44.84124,{"lat":47,"lon":46},[50],{"name":51,"role":32,"phone":19,"phoneExt":19,"email":52},"Elif HINDIE, MD","elif.hindie@chu-bordeaux.fr",{"facility":54,"status":55,"city":56,"state":57,"zip":19,"country":42,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Hôpital LaTimone","NOT_YET_RECRUITING","Marseille","Bouches Du Rhône",{"type":44,"coordinates":59},[60,61],5.38107,43.29695,{"lat":61,"lon":60},[64],{"name":65,"role":32,"phone":19,"phoneExt":19,"email":66},"David TAIEB, MD","David.TAIEB@ap-hm.fr",{"facility":68,"status":39,"city":69,"state":19,"zip":70,"country":42,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle","Montpellier","34298",{"type":44,"coordinates":72},[73,74],3.87635,43.61093,{"lat":74,"lon":73},[77,81],{"name":78,"role":32,"phone":79,"phoneExt":19,"email":80},"Marc Ychou, MD, PhD","33-4-6761-3066","marc.ychou@icm.unicancer.fr",{"name":31,"role":32,"phone":33,"phoneExt":19,"email":82},"aurore.moussion@icm.unicancer.fr",{"facility":84,"status":39,"city":85,"state":19,"zip":86,"country":42,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"Institut Universitaire du Cancer de Toulouse","Toulouse","31100",{"type":44,"coordinates":88},[89,90],1.44367,43.60426,{"lat":90,"lon":89},[93],{"name":94,"role":32,"phone":19,"phoneExt":19,"email":95},"Lawrence DIERICKX, MD","Dierickx.Lawrence@iuct-oncopole.fr",{"type":97,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100370529",false,"NCT04104529","Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department","Establishment of a Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department","BCB RIV","Inclusion Criteria:\n\n* Age ≥ at 18 years old,\n* Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,\n* Patient treated as part of his treatment for:\n\n  * thyroid cancer,\n  * a neuroendocrine tumor or\n  * prostate cancer.\n* Patient having accepted the complementary blood sample,\n* Patient having given his informed, written and express consent.\n\nExclusion Criteria:\n\n* Patient not affiliated to a social security scheme,\n* Subject under tutelage, curatorship or safeguard of justice,\n* Patient in an emergency situation\n* Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons,\n* Pregnant and \u002F or breastfeeding woman","ALL","18 Years",{"count":108,"type":109},350,"ESTIMATED","INTERVENTIONAL",[112],"NA","Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.",[115,116,117],"Thyroid Cancer","Prostate Cancer","Neuroendocrine Tumors",[119,120,121,122],"thyroid cancer","prostate cancer","neuroendocrine tumors","nuclear medecine","2026-06-02",{"date":125,"type":126},"2026-06-04","ACTUAL",{"date":128,"type":126},"2019-10-28",{"date":130,"type":109},"2026-10",{"name":5,"class":6},4]